Cellular and Molecular Life Sciences

, Volume 66, Issue 5, pp 757–772 | Cite as

Stem cell therapy in stroke

  • F. Locatelli
  • A. Bersano
  • E. Ballabio
  • S. Lanfranconi
  • D. Papadimitriou
  • S. Strazzer
  • N. Bresolin
  • G. P. Comi
  • S. Corti
Review

Abstract.

Recent work has focused on cell transplantation as a therapeutic option following ischemic stroke, based on animal studies showing that cells transplanted to the brain not only survive, but also lead to functional improvement. Neural degeneration after ischemia is not selective but involves different neuronal populations, as well as glial and endothelial cell types. In models of stroke, the principal mechanism by which any improvement has been observed, has been attributed to the release of trophic factors, possibly promoting endogenous repair mechanisms, reducing cell death and stimulating neurogenesis and angiogenesis. Initial human studies indicate that stem cell therapy may be technically feasible in stroke patients, however, issues still need to be addressed for use in human subjects.

Keywords.

Stem cell therapy stroke preclinical and clinical studies 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Birkhäuser Verlag, Basel 2008

Authors and Affiliations

  • F. Locatelli
    • 1
  • A. Bersano
    • 2
  • E. Ballabio
    • 2
  • S. Lanfranconi
    • 2
  • D. Papadimitriou
    • 2
  • S. Strazzer
    • 1
  • N. Bresolin
    • 1
    • 2
    • 3
  • G. P. Comi
    • 2
    • 3
  • S. Corti
    • 2
    • 3
  1. 1.IRCCS Eugenio MedeaBosisio PariniLeccoItaly
  2. 2.Dino Ferrari Centre, Department of Neurological SciencesUniversity of Milan, IRCCS Foundation Ospedale Maggiore Policlinico, Mangiagalli and Regina Elena, Padiglione PontiMilanItaly
  3. 3.Centre of Excellence on Neurodegenerative DiseasesUniversity of MilanMilanItaly

Personalised recommendations